Lv6
2292 积分 2022-05-07 加入
中国糖尿病防治指南(2024版)
14天前
已完结
Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
16天前
已完结
From adiposity to multisystem morbidity: the case for weight loss as disease modification
16天前
已完结
Beyond weight loss: multisystem benefits of obesity medications
16天前
已完结
International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery: expert guideline by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)
16天前
已完结
International Federation for the Surgery of Obesity statement on metabolic bariatric surgery after pharmacotherapy-induced weight loss in clinical obesity
16天前
已完结
Clinical obesity in Asian people: bridging the gap between adiposity and disease
16天前
已完结
Diagnosis, staging and management of obesity: a synthesis of contemporary guidelines
16天前
已完结
Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis
16天前
已完结
How May GIP Enhance the Therapeutic Efficacy of GLP-1?
21天前
已完结
皖公网安备34019202002308
